Strategic expansion Schivo’s recent acquisition of Mecaplast SA in Switzerland and expansion activities indicate a growth trajectory and increased manufacturing breadth, presenting cross-sell opportunities to clients seeking integrated plastics, metals, and ceramics capabilities within medical devices.

Molding capabilities With a new President of Molding Technologies to drive R&D and capacity growth, there is a strong signal for advanced molding, prototyping, and scalable production partnerships, ideal for customers needing rapid development and high-volume manufacturing.

End-to-end partner Schivo positions itself as a full-spectrum partner from concept to commercial launch, offering concept design, prototyping, manufacturing, assembly, and delivery, enabling sales plays around complete device lifecycle support for medtech firms.

Tech-enabled operations A tech stack including SAP, AWS, and analytics tools suggests robust operations and data-driven manufacturing, which can be leveraged to pitch improved traceability, quality control, and scalable supply chain for regulated medical devices.

Strategic investments Significant funding and longstanding acquisitions (APN Global, Supreme Screw Products) imply financial stability and a growth-backed roadmap, making Schivo a credible partner for customers seeking reliability, capital-friendly manufacturing partnerships, and potential co-development opportunities.